🇺🇸 Oral contraceptives continuous in United States

FDA authorised Oral contraceptives continuous on 11 May 2001

Marketing authorisations

FDA — authorised 11 May 2001

  • Application: NDA021098
  • Marketing authorisation holder: BAYER HLTHCARE
  • Local brand name: YASMIN
  • Indication: TABLET — ORAL-28
  • Status: approved

Read official source →

FDA

  • Status: approved

Oral contraceptives continuous in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Oral contraceptives continuous approved in United States?

Yes. FDA authorised it on 11 May 2001; FDA has authorised it.

Who is the marketing authorisation holder for Oral contraceptives continuous in United States?

BAYER HLTHCARE holds the US marketing authorisation.